Adult T-cell leukemia primary prevention

Adult T-cell leukemia Microchapters
Home
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Adult T-cell leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-Ray Findings
Echocardiography and Ultrasound
CT scan
MRI Findings
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Adult T-cell leukemia primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Adult T-cell leukemia primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Adult T-cell leukemia primary prevention
CDC on Adult T-cell leukemia primary prevention
Adult T-cell leukemia primary prevention in the news
Blogs on Adult T-cell leukemia primary prevention
Directions to Hospitals Treating Adult T-cell leukemia
Risk calculators and risk factors for Adult T-cell leukemia primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]

Overview

Adult-T cell leukemia is caused by chronic infection with HTLV virus. Primary prevention of adult-T cell leukemia is aimed at preventing the vertical and person-person transmission of HTLV virus.

Primary Prevention

• No preventive vaccine against HTLV-1 is currently available, and interrupting the well-recognized primary modes of HTLV-1 transmission is the mainstay of adult-T cell leukemia prevention,